Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020028 · ClinicalTrials.gov registry record · Phase 2
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
A Phase 2 study of Knee Arthritis, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05020028: Recruiting Phase 2 study of Knee Arthritis, sponsored by NYU Langone Health.
NCT05020028 is a Phase 2 study of Knee Arthritis that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 127-participant average among 7 other Knee Arthritis trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05020028, a Phase 2 study of Knee Arthritis, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can lessen pain, improve function, and improve patient satisfaction in cases of knee osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not produce a 'high' or altered mental state) as compared to tetrahydrocannabinol (THC), another compound found in cannabis. Researchers are studying different forms of CBD for potential use in treating pain, inflammation, and illnesses.
Primary Outcome
A Visual Analogue Scale (VAS) will be used to measure differences in pain between patients receiving CBD with knee OA undergoing physiotherapy compared to patients who do not receive CBD. Patients rate their pain on a scale ranging from 0 (no pain) to 10 (worst pain imaginable). Total scores range from 0-10; higher scores indicates greater pain intensity.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Cannabidiol (CBD)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-06-22 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
What NCT05020028 shows while recruiting
NCT05020028 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 127-participant average among 7 other Knee Arthritis trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Knee Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05020028 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05020028 about?
NCT05020028 is a clinical study titled "Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis". The purpose of this study is to see if cannabidiol (CBD) orally dissolving tablets (ODTs) can lessen pain, improve function, and improve patient satisfaction in cases of knee osteoarthritis. CBD comes from the cannabis plant and is non-psychoactive (i.e. does not produce a 'high' or altered mental s...
What is the current status of trial NCT05020028?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-06-22. Estimated completion is 2026-09.
What conditions does trial NCT05020028 study?
This clinical trial studies the following conditions: Knee Arthritis.
What interventions are being tested in trial NCT05020028?
The interventions under investigation include: Placebo (DRUG), Cannabidiol (CBD) (DRUG).
Who is sponsoring clinical trial NCT05020028?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05020028 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood-Flow Restriction Exercise Following a Knee Replacement
ACTIVE NOT RECRUITING · NA
-
Triathlon All-Polyethylene Tibia Outcomes Study
ACTIVE NOT RECRUITING · NA
-
Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain
ACTIVE NOT RECRUITING · NA
-
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
ACTIVE NOT RECRUITING
-
Preoperative Pain Threshold and Rapid Recover Programs
COMPLETED · NA
-
Gold Factor on Knee Joint Health and Function
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI